2nd Quarter - Report
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ for CHIMERIX, INC.
Client
Income
$20,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 269, The Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 and S. 1379, The Pandemic and All-Hazards Preparedness Act of 2019, provisions related to authorization for medical countermeasures development and procurement; medical countermeasure development and procurement process, generally.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLE CARELLI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.